Webcast Archive: 

For your convenience, an on-demand recording is now available for download. A brief registration is required.  At the conclusion of the webcast, attendees interested in receiving 1.0 contact hour* will need to complete a short on-line evaluation of this program.  Please follow the link below to the evaluation.

Archive Link to December 12th Webcast

Link to Evaluation

For more information on the V-PRO™ 1 Low Temperature Sterilization System

STERIS Webcast VHP^® Technology

This 60-minute webcast presentation is on Vaporized Hydrogen Peroxide, our newest FDA-cleared technology for use in low temperature medical device sterilization.  Enjoy an all-access tour into the science behind the design of one today’s hottest technologies.  Content will be presented by knowledgeable subject matter experts.  Get the inside scoop on key features.  Learn which low temperature modality best fits your needs. 

 Title:  VHP Technology - The New Alternative to Gas Plasma

With so many surgeries, so many delicate instruments, so many different sterilization options and so little time, even the most seasoned sterile processing manager’s head can be left spinning.  The intent of this educational program is to help simplify your choices.  We’ll introduce a new technology and explain how it fits into your world.  We’ll then compare and contrast VHP to existing low temperature modalities such as Plasma, Ozone, EO and Liquid.   Upon completion of the program, you’ll be well equipped to make an informed decision on which technology helps to achieve the clinical, operational and financial goals of your department.

Topics include:

• VHP Overview and Clinical Applications 
• Safety, Efficacy and Compatibility of VHP
• Comparison of VHP to other technologies (Gas Plasma, Ozone, EO, Liquid)

Featured Speakers:

Wallace E. Puckett, BS, Ph.D.

Dr. Wallace E. Puckett has served as the Vice President of Science and Technology for STERIS Corporation since April 2004. His responsibilities include networking globally with the Company's scientific, research and development, marketing, and management staffs to identify and develop new technologies into successful product and service solutions.   Puckett has over 25 years of scientific research and development experience. Prior to joining STERIS Corporation, he served in various senior management positions with Discovery Partners International, Inc., Research and Development Commercialization, Inc., and Buckman Laboratories International, Inc. His research interests include the development of new antimicrobial chemicals and the identification and commercialization of new sterilization technologies.  Puckett holds a Doctorate of Philosophy in Organic Chemistry from Louisiana State University and a Bachelor of Science in Chemistry from the University of Central Florida.

Nancy A. Robinson, BS, Ph.D.

Dr. Robinson is the Director of Advanced Sterilization at STERIS Corporation where she directs a group of microbiologists and chemists responsible for cycle development and efficacy validation of the V-PRO 1 Low Temperature Sterilizer.  Her background includes extensive development/validation experience in liquid and gaseous low temperature chemical sterilization/high level disinfection systems.  Prior to joining STERIS, Dr. Robinson worked in both academic and government research laboratories including the United States Army Medical Research Institute of Infectious Diseases at Fort Detrick, in Frederick, Maryland where she held the rank of US Army Captain.  She is the author of numerous research articles related to her academic tenure and several US patents. She received a BS in Biology and Chemistry from John Carroll University and a PH.D. in Biochemistry from Case Western Reserve University.   

Gerald E. McDonnell, BS, Ph.D.

In his current role as Vice President of Research and European Affairs for STERIS Corporation, Dr. McDonnell is responsible for the development and support of decontamination processes and services, and he provides training on various aspects of decontamination and contamination control.  His basic research interests include infection prevention, decontamination microbiology, emerging pathogens, and modes of action and resistance to biocides.  He has published widely in peer-reviewed journals and books, has been granted patents in decontamination technologies, and frequently gives presentations on various aspects of his work at scientific meetings around the world.  Dr. McDonnell received his BS in Medical Laboratory Sciences from the University of Ulster; and Ph.D. in Microbial Genetics from the University of Dublin.

Michael T. Wright, BS, MBA

In his current role as Product Manager for STERIS Corporation, Mr. Wright assists in the research, design, development and commercialization of low temperature gas sterilization products.  Prior to his role in Healthcare Product Management, Mr. Wright served as a process improvement consultant for an engineering firm serving the biotech/pharmaceutical industry.  Mr. Wright received his BS in Electrical Engineering from Villanova University and his MBA in Marketing and Entrepreneurship from Case Western Reserve University.

Details: 

Date:  Recorded December 12, 2007
Language: English-United States
Time:  At your convenience
Duration:   60 Minutes
Intended Audience:  CS/SPD Managers, OR Managers, Surgical Services, Infection Control, Materials Management
Requirements:  PC with internet connection and audio capability (speakers) 

* “VHP Technology:  The New Alternative to Gas Plasma” for 1.0 contact hour is provided by STERIS Corporation, which is approved as a provider of continuing nursing education by the Michigan Nurses Association, an accredited approver by the American Nurses’ Credentialing Center’s Commission on Accreditation, CBSPD and IAHCSMM.

 Disclaimer:
Participants must view the entire presentation/seminar and complete an online evaluation form to achieve successful completion and receive contact hour credit.  Partial credit will not be given.  All of the presenters are employees of STERIS Corporation and receive no direct compensation other than their normal salaries for participation in this activity.  STERIS Corporation is providing the speakers and contact hours for this activity. However, products referred to or seen during this presentation do not constitute commercial support by the speakers.

If you have questions or feedback, please contact us sterislearning&development@steris.com